Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,810 | 1,490 | 2,790 | 440 | 2,000 |
| Marketable Securities | 0 | 0 | 0 | 2,000 | 0 |
| Other current assets | 40 | 90 | -1 | 2,070 | 2,850 |
| TOTAL | $3,850 | $1,580 | $2,840 | $4,510 | $4,850 |
| Non-Current Assets | |||||
| PPE Net | 420 | 420 | 30 | 420 | 420 |
| Intangibles | 0 | 0 | 7,610 | 0 | 0 |
| Other Non-Current Assets | 7,290 | 7,460 | 20 | 7,790 | 7,960 |
| TOTAL | $7,710 | $7,880 | $7,660 | $8,210 | $8,380 |
| Total Assets | $11,180 | $9,080 | $10,510 | $12,350 | $12,860 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 230 | 130 | 260 | 120 | 140 |
| Accrued Expenses | 640 | 370 | 190 | 540 | 210 |
| Other current liabilities | 140 | 140 | 0 | 0 | 0 |
| TOTAL | $1,020 | $650 | $460 | $660 | $360 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,020 | $650 | $460 | $660 | $360 |
| Shareholders' Equity | |||||
| Common Shares | 60 | 50 | 50 | 50 | 50 |
| Retained earnings | -61,860 | -57,850 | -55,470 | -52,670 | -50,250 |
| Other shareholders' equity | 0 | 0 | 0 | 10 | -10 |
| TOTAL | $10,160 | $8,430 | $10,050 | $11,690 | $12,500 |
| Total Liabilities And Equity | $11,180 | $9,080 | $10,510 | $12,350 | $12,860 |